Effect of pergolide treatment on insulin dysregulation in horses and ponies with pituitary pars intermedia dysfunction.

Background: Due to the high frequency of laminitis reported for both conditions, the relationship between pituitary pars intermedia dysfunction (PPID) and insulin dysregulation (ID), and the potential role of dopamine in modifying insulin secretion, requires further investigation.

Objectives: To evaluate the effect of pergolide mesylate on insulin sensitivity and postprandial insulin and glucose responses in horses and ponies with ID, both with or without concurrent PPID.

Study Design: Randomised crossover study.